524764 — Nutraplus India Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Nutraplus India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 December 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,396 | 1,067 | 0.196 | 0.98 | 0 |
Cost of Revenue | |||||
Gross Profit | 309 | -98.8 | 0.196 | -34.3 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,332 | 1,472 | -118 | 37.5 | 1.28 |
Operating Profit | 63.4 | -405 | 118 | -36.5 | -1.28 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 33.6 | -478 | -189 | -30.3 | -1.57 |
Provision for Income Taxes | |||||
Net Income After Taxes | 21.9 | -478 | -180 | -30.3 | -1.57 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 21.9 | -478 | -237 | -30.3 | -1.57 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 21.9 | -478 | -237 | -30.3 | -1.57 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.09 | -14 | -1.89 | -0.889 | -0.046 |